Please login to the form below

Not currently logged in
Email:
Password:

Astellas appoints new US President and CEO

Astellas has appointed Seigo Kashii as president and CEO of the company's North American subsidiary

Astellas has appointed Seigo Kashii as president and CEO of the company's North American subsidiary.

Kashii's predecessor, Yoshihiko Hatanaka, will become chief strategy officer and chief financial officer at the company's Tokyo headquarters.

"Mr Kashii's outstanding leadership will further strengthen and accelerate the direction Astellas has established in our pursuit of our corporate objectives," said Yoshihiko Hatanaka. "Mr Kashii's ability to deliver results and his deep understanding of our science-driven business make him an excellent choice to continue positioning Astellas as a category leader."

Kashii has worked for Astellas for over 30 years holding positions in legal affairs, corporate planning and strategy, and also as a medical sales rep in Japan. He served as corporate executive and vice president of legal for for Astellas Pharma.

2nd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics